Levels of SARS-COV-2 anti-spike protein receptor-binding domain (S-RBD) IgG in Indonesian-vaccinated healthcare workers: experimental research.
Betty Agustina TambunanI Dewa G UgrasenaJusak NugrahaMunawaroh FitriahCynthia A PermatasariEmmanuel J MosesNarazah M Yusoff AryatiPublished in: Annals of medicine and surgery (2012) (2023)
SARS-CoV-2 anti-S-RBD IgG antibody levels increased significantly until day 14 after the second dose; the levels decreased gradually after day 28. Ten participants (20%) were infected with SARS-CoV-2, with mild symptoms.